Scrutinize the data and tweets to envisage if the closing price of $pfe will swell or contract at 2017-02-24. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-09,-0.7,0.5,-0.7,0.7,0.7,-0.6,-1.8,-2.6,-2.3,-1.5,-1.2
2017-02-10,0.2,0.3,-0.4,-0.1,-0.1,-0.4,-1.4,-2.3,-2.2,-1.5,-1.1
2017-02-13,-0.5,0.2,-0.5,0.8,0.8,-0.9,-1.7,-2.8,-2.9,-2.3,-1.8
2017-02-14,-0.7,0.1,-1.2,0.4,0.4,-0.9,-1.7,-2.8,-3.2,-2.8,-2.2
2017-02-15,-2.2,0.2,-2.4,2.3,2.3,-2.4,-3.4,-4.5,-5.1,-5.0,-4.3
2017-02-16,-0.5,0.8,-1.2,0.3,0.3,-1.9,-3.1,-4.3,-5.1,-5.1,-4.6
2017-02-17,-0.1,0.8,-0.3,0.0,0.0,-1.2,-2.7,-3.8,-4.8,-5.0,-4.5
2017-02-21,-0.1,0.5,-0.4,0.0,0.0,-0.6,-2.2,-3.3,-4.4,-4.8,-4.5
2017-02-22,-0.1,0.5,-1.0,-0.1,-0.1,0.0,-1.7,-2.8,-3.9,-4.5,-4.4
2017-02-23,-1.1,0.2,-1.4,1.4,1.4,-1.1,-2.5,-3.6,-4.8,-5.5,-5.6

2017-02-09: following a strategic evaluation, $pfe decides to close adelaide manufacturing facility |$pfe er was jan 31.... if they're bullish, it may be because of the rumor that $pfe may likely be making a much
2017-02-10: rt AT_USER cellectis $alcls $clls $pfe 2nd target disclosed - after bcma in mm, egfrviii in gbm (not a surprise at all) #aacr17 |$xom $amzn $googl $avgo $aapl $pfe $cvs $bac $td $wmt $cost $wfc $jnj $
2017-02-11: $pfe backtracks on expansion plans, aims to close australian plant by 2021 |rt AT_USER $ko $cce $icnb $sbux $bud $tbev $usmj $pura $fb $googl $goog $twtr $bas $pfe $ge $pep $brew $dps $ftci $mnst $bb 
2017-02-12: rt AT_USER pharma m&amp;a in 2017: the most likely deal hunters  $amgn $gild $mrk $pfe|rt AT_USER pharma stocks getting clobbered.. great buying opportunity for the long term! $bmy $agn $abbv $pfe $mr
2017-02-13: #pfizer to shut australian neulasta biosimilar plant and move production to croatia. read more:  $pfe|q4 scorecard &amp; analyst reports for #pfizer, boeing &amp; goldman sachs. read more:  $pfe|9 top
2017-02-14: introducing first, from the retail corner: $tgt, $bby, $jcp and allies; from the export corner: $ba, $ge, $pfe and¡­ |rt AT_USER streetinsider- $bmy is in play, $rog $nvs $pfe "thought to be kicking t
2017-02-15: how is $pfe connecting with rhematoid arthritis patients? a relationship expert, of course |how is $pfe connecting with rhematoid arthritis patients? a relationship expert, of course |investing rookie
2017-02-16: valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |why this billionaire just shelled out $1.1 billion on 4 drug stocks AT_USER #stoc
2017-02-17: $pfe gets fda warning letter related to compliance at the facility used to make glatopa products #ascendtrading|scan results - shooting star candlestick today: $mtdr $amt $pfe $cva $kr $avxs $acet $fp
2017-02-18: $pfe better buy: gilead sciences, inc. vs. pfizer inc. |$spx spdr health care sector etf components. $bmy $gld $unh $abbv $biib $jnj $mdt $xlv $lly $pfe $celg $mrk $tmo¡­ |rt AT_USER lobbyist for $amg
2017-02-19: rt AT_USER hedge fund guru david tepper just put $1.1b into 4 pharmas. are these drugmakers right for you? |$pfe's xeljanz isn't able to best a rival drug from $abbv |rt AT_USER $ko $ge $icnb $sbux $b
2017-02-20: #pfizer hit with us fda warning at kansas generic copaxone site. read more:  $pfe|$pfe - pfizer inc short - failed to break resistance levels - |this biotech etf looks primed to rally again $ibb $xbi 
2017-02-21: AT_USER AT_USER AT_USER that kind of m&amp;a to be accretetive require a much overlap for cost cutting i see  $gsk $pfe $nvs $san roche?|celltrion healthcare &amp; $pfe pfizer's biosimilar of #inflixi
2017-02-22: $ko $mcd $mmm $mrk $msft $nke $pfe long and short positions from the dow jones, up to 1800% since 2008.  $djia $dia|$pfe who could buy bristol-myers squibb? |momenta says #pfizer will fix plant but re
2017-02-23: 7 blue-chip stocks that are flush with cash $aapl $ge $jnj $ko $msft $googl $pfe  |rt AT_USER twiddling my thumbs until monday ||  || $study $low $pgx $pfe $xrx #investing #trading #stocks #edu¡­|rt A
Answer:
Rise